Yahoo Web Search

Search results

1. • 

     Human ‘challenge trials’ entail risk but they could be our best protection against the next pandemic

     The Telegraph via Yahoo News· 1 day ago

     Fifty years ago this month, as the seasonal smallpox epidemic raged to a peak in India, nobody knew...

2. • Ensysce Biosciences Regains Compliance with Nasdaq

     Digital Journal· 22 hours ago

     North of Soledar, Ukrainians yearn for peace Carlo Marks talks about his new Hallmark movie ‘The Wedding Veil Inspiration’ Musk faces US fraud trial over Tesla tweet Heat ...

3. • 

     Earnings call: Nanobiotix reports Q1 2024 results, advances with NBTXR3

     Investing.com· 6 days ago

     Significant strides were made in their collaboration with Janssen on the NBTXR3 development plan,...

4. • Further CYP-001 GvHD Clinical Data Published in Nature Medicine

     NBC 10 - FOX 14 Monroe· 7 days ago

     Cynata Therapeutics Limited (ASX: "CYP", "Cynata", or the "Company"), a clinical-stage biotechnology company specialising in cell therapeutics, is pleased to announce the ...

5. • 

     Researchers point powerful ultrasound technology at the next frontier — addiction

     U-T San Diego· 1 day ago

     Beams of ultrasound waves fire into a tiny sector of the woman’s brain by the hundreds — an...

6. • Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald

     Roanoke-Chowan News-Herald· 2 hours ago

     Jeito Capital announces the acquisition by Merck & Co (NYSE: MRK)of its portfolio company EyeBio for a potential value of $3 billion This acquisition reflects the significant clinical ...

7. • 

     Earnings call: IceCure reports 30% increase in Q1 product sales By Investing.com

     Investing.com· 3 hours ago

     IceCure Medical (ICCM), a company specializing in cryoablation treatments, has reported a 30%...

8. • Zanidatamab Granted Priority Review for HER2-Positive Metastatic Biliary Tract Cancer - Jazz...

     Benzinga· 1 hour ago

     Target Action (PDUFA) Date set for November 29, 2024 If approved, zanidatamab will be the first HER2-targeted treatment specifically indicated for patients with HER2+ locally advanced or metastatic biliary tract

9. • 

     Study: Ozempic boosts health, survival of patients with kidney disease, Type 2 diabetes

     United Press International via Yahoo News· 5 days ago

     The drug significantly reduces the risk of severe kidney events, heart problems...patients who have...

10. • 

      Terran Biosciences prepares for trials of schizophrenia drug

      Clinical Trials Arena via Yahoo Finance· 5 days ago

      Schizophrenia landscape Schizophrenia is a chronic and debilitating mental illness that affects...